Science
Mechanism of Action
Tranexamoyl Dipeptide-23 operates through a dual mechanism to combat hyperpigmentation by inhibiting tyrosinase, the key enzyme in melanin synthesis, and by downregulating MITF, which controls melanocyte development and proliferation. Furthermore, it strengthens the skin barrier, provides significant anti-inflammatory and anti-allergic benefits, and supports collagen integrity to diminish the appearance of fine lines and wrinkles.
Research
Clinical Evidence
High confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Stability in formulations is significantly enhanced by its modification with Tranexamic acid. For maximum stability during storage, peptides generally require temperatures below -15 °C, with solutions best stored in aliquots and frozen.
Synergies
- Tranexamic Acid (for enhanced stability and efficacy)
Safety
Safety Profile
Cytotoxicity studies affirm Tranexamoyl Dipeptide-23's safety for skincare applications, showing no reported toxicity. Its low irritancy profile further supports its suitability for various skin types.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Tranexamoyl Dipeptide-23 is a highly valuable, clinically supported active ingredient offering superior brightening, anti-aging, and soothing benefits with excellent skin compatibility across all skin types.
Related
Similar Ingredients
Finding similar ingredients…